We are live on ! Find out more
KC

Kryger Capital Portfolio holdings

AUM $1.75B
1-Year Est. Return 102.57%
This Fund
S&P 500
This Quarter Est. Return
+11.9%
1 Year Est. Return
+102.57%
3 Year Est. Return
+420.51%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.75B
AUM Growth
+$339M
Cap. Flow
+$244M
Cap. Flow %
13.93%
Top 10 Hldgs %
74.92%
Holding
148
New
72
Increased
20
Reduced
17
Closed
39

Top Buys

Rank Stock Value
1
NSC icon
Norfolk Southern
NSC
+$72.8M
2
GTLS
Chart Industries
GTLS
+$71.1M
3
APGE
Apogee Therapeutics
APGE
+$66.9M
4
AES icon
AES
AES
+$66.7M
5
KVUE icon
Kenvue
KVUE
+$58.8M

Top Sells

Rank Stock Value
1
CWAN
Clearwater Analytics
CWAN
+$90.3M
2
DAWN
Day One Biopharmaceuticals
DAWN
+$83.5M
3
FOLD
Amicus Therapeutics
FOLD
+$65.9M
4
HOLX
Hologic
HOLX
+$62.1M
5
AL
Air Lease Corp
AL
+$57M

Sector Composition

Rank Sector Weight
1 Industrials 24.67%
2 Financials 22.06%
3 Communication Services 18.07%
4 Healthcare 12.34%
5 Consumer Staples 9.32%

No holdings matched the selected filter criteria.

2 3 4 5 6

Similar funds

L7C
Liberty 77 Capital Washington, District of Columbia $1.75B AUM 88.73% 1-Year Est. Return
SB
Simmons Bank Pine Bluff, Arkansas $1.75B AUM 33.61% 1-Year Est. Return
FTS
Fifth Third Securities Cincinnati, Ohio $1.75B AUM 21.97% 1-Year Est. Return
PIM
Plato Investment Management Sydney, NSW, Australia $1.75B AUM 41.21% 1-Year Est. Return
RCW
Rheos Capital Works Tokyo, Japan $1.75B AUM 57.75% 1-Year Est. Return
AG
Atairos Group Bryn Mawr, Pennsylvania $1.76B AUM 16.47% 1-Year Est. Return
KC
Kepler Cheuvreux Nyon $1.75B AUM 37.37% 1-Year Est. Return
MJRIC
Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return

Kryger Capital's Q2 2026 Portfolio in Review

As of Q2 2026, Kryger Capital held 148 positions worth $1.75B, up 24% from $1.41B the previous quarter. Its ten largest holdings account for 75% of the portfolio.

Kryger Capital deployed $244M of net new capital in Q2 2026, opening 72 new positions and adding to 20 existing holdings. Its largest new stake was Apogee Therapeutics: 742,555 shares worth $98.6M.

By sector, the portfolio is most concentrated in Industrials at 25% of assets, up from 23% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was Penumbra, an estimated $15.1M trimmed.

  • Kryger Capital's largest Q2 2026 buy was Apogee Therapeutics: 742,555 shares worth $98.6M.
  • Kryger Capital added most to Norfolk Southern in Q2 2026, an estimated $72.8M increase.
  • Kryger Capital's biggest Q2 2026 reduction was Penumbra, cutting an estimated $15.1M.
  • Kryger Capital fully exited Clearwater Analytics in Q2 2026, selling an estimated $90.3M.
  • Kryger Capital's ten largest holdings make up 75% of its $1.75B portfolio in Q2 2026.
  • Kryger Capital opened 72 new positions and closed 39 in Q2 2026.
  • Kryger Capital's portfolio value rose 24% quarter-over-quarter to $1.75B.

Based on Kryger Capital's 13F filing for Q2 2026, filed 14 Aug 2026.